Bal Pharma Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bal Pharma Limited with three other
companies in this sector in India:
Bajaj Healthcare Ltd
sales of 2.00 billion Indian Rupees [US$31.22 million]
of which 95%
Gufic Biosciences Ltd
(2.02 billion Indian Rupees [US$31.52 million]
Syncom Formulations (India) Limited
(1.84 billion Indian Rupees [US$28.67 million]
Bal Pharma Limited reported sales of 1.98 billion Indian Rupees (US$30.92 million)
March of 2016.
increase of 6.0%
versus 2015, when the company's sales were 1.87 billion Indian Rupees.
Sales at Bal Pharma Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 76%).